Sam Isaly, founder of the biotech hedge fund OrbiMed Advisors, is leaving the firm following allegations of sexual harassment, Stat News reports. It notes, however, that OrbiMed says in a statement that the 72-year-old Isaly is taking a planned retirement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.